

| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | apixaban | FAERS: 4 | US FAERS | |
| 2 | Exenatide | FAERS: 2 | US FAERS | |
| 3 | NuvaRing | FAERS: 2 | US FAERS | |
| 4 | Octreotide | FAERS: 2 | US FAERS | |
| 5 | Alendronate | FAERS: 1 | US FAERS | |
| 6 | Dabigatran | FAERS: 1 | US FAERS | |
| 7 | Deferasirox | FAERS: 1 | US FAERS | |
| 8 | Ertapenem | FAERS: 1 | US FAERS | |
| 9 | Olmesartan Medoxomil | FAERS: 1 | US FAERS | |
| 10 | PCI 32765 | FAERS: 1 | US FAERS | |
| 11 | Rasilez HCT | FAERS: 1 | US FAERS | |
| 12 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 13 | Rosiglitazone | FAERS: 1 | US FAERS | |
| 14 | Tiopronin | FAERS: 1 | US FAERS | |
| 15 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 16 | mirabegron | FAERS: 1 | US FAERS | |
| 17 | 2-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chloride | OFFSIDES | ||
| 18 | Aminocaproic Acid | OFFSIDES | ||
| 19 | Ampicillin | OFFSIDES | ||
| 20 | Bortezomib | OFFSIDES | ||
| 21 | Bupropion | OFFSIDES | ||
| 22 | Chlorhexidine | OFFSIDES | ||
| 23 | Diphenoxylate | OFFSIDES | ||
| 24 | Lenalidomide | OFFSIDES | ||
| 25 | Letrozole | OFFSIDES | ||
| 26 | Nateglinide | OFFSIDES | ||
| 27 | Octreotide | OFFSIDES | ||
| 28 | Pamidronate | OFFSIDES | ||
| 29 | Penicillin V | OFFSIDES | ||
| 30 | Phenazopyridine | OFFSIDES | ||
| 31 | Zoledronic Acid | OFFSIDES | ||
| 32 | chlorhexidine gluconate | OFFSIDES | ||
| 33 | mizoribine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.